3 results  1 of 1 

1 Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
Kazufumi Dohmen, Shin-ya Onohara, Shigeru Harada
Korean J Gastroenterol.2021;78(4):227-234.   Published online 2021 October 25     DOI: http://dx.doi.org/10.4166/kjg.2021.092
      
2 Activation of PPARα Attenuates IFNγ and IL-1β-induced Cell Proliferation in Astrocytes: Involvement of IL-6 Independent Pathway
Jin-Koo Lee, Eun-Min Seo, Sang-Soo Lee, Soo-Hyun Park, Yun-Beom Sim, Jun-Sub Jung, Seon-Mi Kim, Hong-Won Suh
Korean J Physiol Pharmacol.2010;14(3):185-189.   Published online 2010 February 18     DOI: http://dx.doi.org/10.4196/kjpp.2010.14.3.185
   
3 Effect of Bezafibrate(Bezalip®)in Patients with Hyperlipidemia
Chee Jeong Kim, Young Dae Kim, Dong Jin Oh, Byung Hee Oh, Myoung Mook Lee, Young Bae Park, Yun Shik Choi, Jung Don Seo, Young Woo Lee
Korean Circ J.1989;19(3):497-502.   Published online 1989 September 30     DOI: http://dx.doi.org/10.4070/kcj.1989.19.3.497
      

 1 of 1